Latest Oragenics Inc. Stories

2004-11-30 12:00:00

ALACHUA, Fla. -- Oragenics Inc. plans to start human safety studies of its replacement therapy early next year, using a genetically modified bacteria to battle decay caused by naturally occurring microbes already in the mouth. The Food and Food and Drug Administration on Tuesday lifted a clinical hold on the tooth decay treatment. In a press release Tuesday, the Alachua, Fla.-based biotechnology company said the FDA approved a Phase I trial after reviewing the study's clinical design. "The...

Word of the Day
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.